Early intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathy

Early intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathy

Item
http://www.wikidata.org/entity/Q37713229
Long-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 years.Tafamidis delays disease progression in patients with early stage transthyretin familial amyloid polyneuropathy: additional supportive analyses from the pivotal trial.When proteostasis goes bad: Protein aggregation in the cell.Treatment With Tafamidis Slows Disease Progression in Early-Stage Transthyretin Cardiomyopathy.Peptide probes detect misfolded transthyretin oligomers in plasma of hereditary amyloidosis patients.Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.Transthyretin familial amyloid polyneuropathy: an update.Hip and knee arthroplasty are common among patients with transthyretin cardiac amyloidosis, occurring years before cardiac amyloid diagnosis: can we identify affected patients earlier?Tafamidis delays neurological progression comparably across Val30Met and non-Val30Met genotypes in transthyretin familial amyloid polyneuropathy.A Missense Variant p.Ala117Ser in the Transthyretin Gene of a Han Chinese Family with Familial Amyloid Polyneuropathy.Positive Effectiveness of Tafamidis in Delaying Disease Progression in Transthyretin Familial Amyloid Polyneuropathy up to 2 Years: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS).Understanding the Disease Course and Therapeutic Benefit of Tafamidis Across Real-World Studies of Hereditary Transthyretin Amyloidosis with Polyneuropathy: A Proof of Concept for Integrative Data Analytic Approaches.Storage diseases with hypertrophic cardiomyopathy phenotype
P2860

Early intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathy

Item
http://www.wikidata.org/entity/Q37713229
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Early intervention with tafami ...... editary amyloid polyneuropathy
@en
Early intervention with tafamidis provides long-term
@nl
type
label
Early intervention with tafami ...... editary amyloid polyneuropathy
@en
Early intervention with tafamidis provides long-term
@nl
prefLabel
Early intervention with tafami ...... editary amyloid polyneuropathy
@en
Early intervention with tafamidis provides long-term
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
Early intervention with tafami ...... editary amyloid polyneuropathy
@en
P2093
P2860
P304
P31
P356
10.1080/13506129.2016.1207163
P433
P478
P577
P698
P932